Array BioPharma Inc. (ARRY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.52-0.06 (-0.91%)
As of 1:19 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close6.58
Bid6.53 x 900
Ask6.54 x 2000
Day's Range6.46 - 6.61
52wk Range2.38 - 7.27
1y Target EstN/A
Market Cap1.06B
P/E Ratio (ttm)-10.03
Avg Vol (3m)5,757,826
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Zacks7 days ago

    Array BioPharma (ARRY) is in Overbought Territory: What's Next?

    Array BioPharma Inc. (ARRY) has moved higher as of late, but there could definitely be trouble on the horizon for this company

  • Capital Cube10 days ago

    ETF’s with exposure to Array BioPharma, Inc. : October 11, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Array BioPharma, Inc. Here are 5 ETF’s with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Why Array BioPharma Skyrocketed 91% in September
    Motley Fool11 days ago

    Why Array BioPharma Skyrocketed 91% in September

    News that the FDA will weigh in with an approval decision next summer for the company's most advanced drug was followed up later in the month by positive data from an important late-stage study. That one-two combination of positive news sparked investor enthusiasm and sent shares soaring.